SAP

246.35

+0.72%↑

ASML

596.4

-1.11%↓

DSY

27.8

-0.5%↓

STMPA.FR

21.57

-0.78%↓

NOKIA.FI

3.52

-0.28%↓

SAP

246.35

+0.72%↑

ASML

596.4

-1.11%↓

DSY

27.8

-0.5%↓

STMPA.FR

21.57

-0.78%↓

NOKIA.FI

3.52

-0.28%↓

SAP

246.35

+0.72%↑

ASML

596.4

-1.11%↓

DSY

27.8

-0.5%↓

STMPA.FR

21.57

-0.78%↓

NOKIA.FI

3.52

-0.28%↓

SAP

246.35

+0.72%↑

ASML

596.4

-1.11%↓

DSY

27.8

-0.5%↓

STMPA.FR

21.57

-0.78%↓

NOKIA.FI

3.52

-0.28%↓

SAP

246.35

+0.72%↑

ASML

596.4

-1.11%↓

DSY

27.8

-0.5%↓

STMPA.FR

21.57

-0.78%↓

NOKIA.FI

3.52

-0.28%↓

Kodu・Aktsiate loetelu・GFT Technologies SE

G
GFT Technologies SE

Suletud

17.48 0.58

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

17.12

Max

17.64

Põhinäitajad
By Trading Economics
Sissetulek	-5.5M 7.1M
Müük	-3.5M 222M
P/E Sektori keskmine	10.915 71.636
Aktsiakasum	0.269
Kasumimarginaal	3.195
Töötajad	11,506
EBITDA	-7.6M 17M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+68.57% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	7. aug 2025

Turustatistika
By TradingEconomics
Turukapital	-20M 600M
Eelmine avamishind	16.9
Eelmine sulgemishind	17.48

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

22.6 / 24.8 Toetus ja vastupanu

GFT Technologies SE Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. aug 2025, 21:42 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4. aug 2025, 21:21 UTC

Tulu

Suurimad hinnamuutused turgudel

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4. aug 2025, 20:45 UTC

Tulu

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4. aug 2025, 19:15 UTC

Suurimad hinnamuutused turgudel

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4. aug 2025, 23:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4. aug 2025, 23:41 UTC

Market Talk

Nikkei May Rise on Fed Stimulus Hopes

4. aug 2025, 23:28 UTC

Market Talk

Global Equities Roundup: Market Talk

4. aug 2025, 23:28 UTC

Market Talk

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4. aug 2025, 21:30 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4. aug 2025, 21:21 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4. aug 2025, 21:18 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4. aug 2025, 20:25 UTC

Market Talk

India Hits Back Over Russian Oil Purchases -- Market Talk

4. aug 2025, 20:25 UTC

Tulu

Transocean 2Q Loss $938M >RIG

4. aug 2025, 20:25 UTC

Tulu

Transocean 2Q Loss/Shr $1.06 >RIG

4. aug 2025, 20:18 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4. aug 2025, 20:15 UTC

Tulu

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4. aug 2025, 20:13 UTC

Tulu

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4. aug 2025, 20:09 UTC

Tulu

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4. aug 2025, 20:06 UTC

Tulu

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4. aug 2025, 19:41 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

4. aug 2025, 19:28 UTC

Market Talk

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4. aug 2025, 19:07 UTC

Market Talk

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4. aug 2025, 18:27 UTC

Market Talk

Gold Climbs on Rate Cut Speculation -- Market Talk

Võrdlus sarnastega

Hinnamuutus

GFT Technologies SE Prognoos

Hinnasiht

By TipRanks

68.57% tõus

12 kuu keskmine prognoos

Keskmine 29.5 EUR 68.57%

Kõrge 32 EUR

Madal 28 EUR

Põhineb 4 Wall Streeti analüütiku instrumendi GFT Technologies SE 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi GFT Technologies SE aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

22.6 / 24.8Toetus ja vastupanu

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest GFT Technologies SE

GFT Technologies SE, together with its subsidiaries, provides digital transformation services. The company operates in two segments in the Americas, the UK & APAC; and Continental Europe. It offers consulting on the development and implementation of IT strategies; development of bespoke IT solutions; implementation of sector-specific software; and maintenance and development of business-critical IT solutions. The company serves clients in investment and retail banking, insurance, and industrial sectors. It operates in Brazil, Germany, France, the United Kingdom, Hong Kong, Italy, Canada, Mexico, Poland, Switzerland, Singapore, Spain, the United States, and internationally. GFT Technologies SE was founded in 1987 and is headquartered in Stuttgart, Germany.